Evidence map›Paper›PMID 37475638›Full record

ArticleBiostatistics (Oxford, England)2024

Tree-based subgroup discovery using electronic health record data: heterogeneity of treatment effects for DTG-containing therapies.

Jiabei Yang, Ann W Mwangi, Rami Kantor, Issa J Dahabreh, Monicah Nyambura, Allison Delong, Joseph W Hogan, Jon A Steingrimsson

Open access · greenAbstract read
In one paragraph

Article in Biostatistics (Oxford, England), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. SubgroupTE: Advancing Treatment Effect Estimation with Subgroup Identification.ACM transactions on intelligent systems and technology · 2025
    Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Jiabei YangDepartment of Biostatistics, School of Public Health, Brown University, Providence, RI 02903, USA.ORCID 0000-0002-1919-1455
Ann W MwangiDepartment of Mathematics, Physics and Computing, School of Science and Aerospace Studies, Moi University, Eldoret 30100, Kenya.
Rami KantorDivision of Infectious Diseases, Warren Alpert Medical School, Brown University, Providence, RI 02903, USA.
Issa J DahabrehCAUSALab, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.ORCID 0000-0002-2215-9931
Monicah NyamburaAcademic Model Providing Access to Healthcare (AMPATH), Eldoret 30100, Kenya.
Allison DelongDepartment of Biostatistics, School of Public Health, Brown University, Providence, RI 02903, USA.
Joseph W HoganDepartment of Biostatistics, School of Public Health, Brown University, Providence, RI 02903, USA.
Jon A SteingrimssonDepartment of Biostatistics, School of Public Health, Brown University, Providence, RI 02903, USA.
Brown University · USAMPATH · KEHarvard University · USMoi University · KE

Funding

Tracking and Evaluation CoreU54GM115677 · NIGMS · BROWN UNIVERSITY · PI TOVAR, ALISON · 2016 to 2025
$45.0M
Methods for generalizing inferences from cluster randomized controlled trials to target populationsR01LM013616 · NLM · HARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH · PI DAHABREH, ISSA J. · 2022 to 2025
$1.4M
HIV Drug Resistance, Monitoring and TransmissionK24AI134359 · NIAID · MIRIAM HOSPITAL · PI Rami Kantor · 2018 to 2026
$1.3M
NIAID NIH HHS K24 AI134359NIGMS NIH HHS U54 GM115677NLM NIH HHS R01 LM013616NLM NIH HHS R01LM013616Patient-Centered Outcomes Research Institute ME-2019C3-17875
6 · The paper itself

Abstract

The rich longitudinal individual level data available from electronic health records (EHRs) can be used to examine treatment effect heterogeneity. However, estimating treatment effects using EHR data poses several challenges, including time-varying confounding, repeated and temporally non-aligned measurements of covariates, treatment assignments and outcomes, and loss-to-follow-up due to dropout. Here, we develop the subgroup discovery for longitudinal data algorithm, a tree-based algorithm for discovering subgroups with heterogeneous treatment effects using longitudinal data by combining the generalized interaction tree algorithm, a general data-driven method for subgroup discovery, with longitudinal targeted maximum likelihood estimation. We apply the algorithm to EHR data to discover subgroups of people living with human immunodeficiency virus who are at higher risk of weight gain when receiving dolutegravir (DTG)-containing antiretroviral therapies (ARTs) versus when receiving non-DTG-containing ARTs.

Indexed as

Electronic Health RecordsHeterocyclic Compounds, 3-RingHIV InfectionsPiperazinesPyridonesDolutegravirHumansOxazinesTreatment Effect HeterogeneityDolutegravirHeterocyclic Compounds, 3-RingOxazinesPiperazinesPyridonesCausal inferenceDolutegravirElectronic health recordHeterogeneity of treatment effectsLongitudinal targeted maximum likelihood estimationMachine learningRecursive partitioningSubgroup discovery

Identifiers

PMID37475638
PMCPMC11017113
OpenAlexW4384922066

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.